Drug Patents owned by Jazz

1. Drug name - SUNOSI

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8877806 JAZZ Treatment of sleep-wake disorders Jun, 2026

(3 years from now)

US10351517 JAZZ Treatment of sleep-wake disorders Jun, 2026

(3 years from now)

US9604917 JAZZ Treatment of sleep-wake disorders Jun, 2026

(3 years from now)

US8440715 JAZZ Treatment of sleep-wake disorders Aug, 2027

(4 years from now)

US10195151 JAZZ Formulations of (R)-2-amino-3-phenylpropyl carbamate Sep, 2037

(14 years from now)

US10512609 JAZZ Formulations of (R)-2-amino-3-phenylpropyl carbamate Sep, 2037

(14 years from now)

US10912754 JAZZ Methods and compositions for treating excessive sleepiness Jun, 2038

(15 years from now)

US10959976 JAZZ Methods and compositions for treating excessive sleepiness Jun, 2038

(15 years from now)

US10940133 JAZZ Methods of providing solriamfetol therapy to subjects with impaired renal function Mar, 2040

(17 years from now)

Drugs and Companies using SOLRIAMFETOL HYDROCHLORIDE ingredient

Treatment: To improve wakefulness in adult patients with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea (osa); Treatment of excessive daytime sleepiness associated with obstructive sleep apnea (osa) in an adult through a dosing regimen that includes oral administration of 75 mg once daily for at least 3 days followed by 150 mg once daily; To improve wakefulness in adult patients with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea (osa) with a dosing regimen that includes a dose of 75 mg once daily for at least 3 days followed by 150 mg once daily; Treatment of excessive daytime sleepiness associated with obstructive sleep apnea (osa) in a patient with moderate renal impairment

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 75MG BASE TABLET;ORAL Prescription
EQ 150MG BASE TABLET;ORAL Prescription

2. Drug name - XYWAV

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8731963 JAZZ Sensitive drug distribution system and method Dec, 2022

(2 months from now)

US8591922 JAZZ Gamma-hydroxybutyrate compositions and their use for the treatment of disorders Jan, 2033

(10 years from now)

US10675258 JAZZ Method of using gamma-hydroxybutyrate compositions for the treatment of disorders Jan, 2033

(10 years from now)

US8901173 JAZZ Gamma-hydroxybutyrate compositions and their use for the treatment of disorders Jan, 2033

(10 years from now)

US10195168 JAZZ Gamma-hydroxybutyrate compositions and their uses for the treatment of disorders Jan, 2033

(10 years from now)

US9132107 JAZZ Gamma-hydroxybutyrate compositions and their use for the treatment of disorders Jan, 2033

(10 years from now)

US10864181 JAZZ Method of administration of gamma hydroxybutyrate with monocarboxylate transporters Mar, 2033

(10 years from now)

US8772306 JAZZ Method of administration of gamma hydroxybutyrate with monocarboxylate transporters Mar, 2033

(10 years from now)

US10213400 JAZZ Method of administration of gamma hydroxybutyrate with monocarboxylate transporters Mar, 2033

(10 years from now)

US9050302 JAZZ Method of administration of gamma hydroxybutyrate with monocarboxylate transporters Mar, 2033

(10 years from now)

US9486426 JAZZ Method of administration of gamma hydroxybutyrate with monocarboxylate transporters Mar, 2033

(10 years from now)

Drugs and Companies using CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE ingredient

Treatment: Method of treating a patient with a prescription drug using a computer database in a computer system for distribution; Treatment of cataplexy or excessive daytime sleepiness (eds) in patients 7 years of age and older with narcolepsy with a mixture of sodium, potassium, magnesium, and calcium salts of ghb; Method of treating excessive daytime sleepiness and/or cataplexy in narcolepsy patients with a salt of gamma-hydroxybutyrate when divalproex sodium is concomitantly administered; Method of treating patients with idiopathic hypersomnia with sodium oxybate when divalproex sodium is concomitantly administered; method of treating excessive daytime sleepiness and/or cataplexy in narcolepsy patients with sodium oxybate when divalproex sodium is concomitantly administered.; Method of reducing adverse effects in patients suffering from excessive daytime sleepiness and/or cataplexy in narcolepsy who are concomitantly administered sodium oxybate and divalproex sodium; Method of treating excessive daytime sleepiness and/or cataplexy in narcolepsy patients with sodium oxybate when divalproex sodium is concomitantly administered.

Dosage: SOLUTION;ORAL

More Information on Dosage
Strength Dosage Availability
0.234GM/ML;0.096GM/ML;0.13GM/ML;0.04GM/ML SOLUTION;ORAL Prescription

3. Drug name - ZEPZELCA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7763615 JAZZ Ecteinascidin analogs for use as antitumour agents
Dec, 2024

(2 years from now)

CN100334094C JAZZ Antitumoral Analogs
Aug, 2022

(a month ago)

CN1564822A JAZZ Anti-Tumour Thereof
Aug, 2022

(a month ago)

IN246010B JAZZ Antitumoral Analogues Of Ecteinascidin
Aug, 2022

(a month ago)

IN200400232P1 JAZZ Antitumoral Analogues Of Ecteinascidi
Aug, 2022

(a month ago)

EP1414828B1 JAZZ Antitumoral Analogs
Aug, 2022

(a month ago)

EP1414828A1 JAZZ Antitumoral Analogs
Aug, 2022

(a month ago)

EP1414828B9 JAZZ Antitumoral Analogs
Aug, 2022

(a month ago)

Drugs and Companies using LURBINECTEDIN ingredient

Treatment: NA

Dosage: POWDER;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
4MG/VIAL POWDER;INTRAVENOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.